Nicotinamide (Hanlim Pharm)

尼克酰胺 (韩林制药株式会社)

Report date: 2025/03/25 09:15:43

Base Information

Drug NameNicotinamide (Hanlim Pharm)
Drug Alias NameN/A
ClassificationSmall molecules > Amino acid supplement, Lipids and Vitamins
Mechanisms of ActionMitogen-activated protein kinase inhibitors
TargetsMitogen-activated protein kinase
Therapy Area/IndicationsGlaucoma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySouth Korea
CombinationsNo
Global Highest StatusClinical
Highest Status in ChinaN/A
Originator CompaniesHanmi Pharmaceutical Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesHanmi Pharmaceutical Co Ltd
Inactive CompaniesN/A
Active IndicationsGlaucoma
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A